Untitled-1

Biotechnology Center as a COVID-19 Diagnostic Center

It is apparent that Cameroon, although haven put so much effort to try and control the COVID-19 pandemic, continuously put resources in place in order to control the pandemic. One of the major resolutions adopted by the government is trying to strengthen multisectoral coordination, of investigating and confirming all the suspicious cases. As part of the strengthening of surveillance and monitoring of COVID-19 cases, the ministry of public health appointed many laboratories with the technical platform and human resources nationwide, BTC included as diagnostic centers for COVID 19.

The biotechnology Center Diagnostic team

The ongoing pandemic COVID-19, caused by SARS-CoV-2, has already resulted in more than 3 million cases and more than 200,000 deaths globally. Significant clinical presentations of COVID-19 include respiratory symptoms and pneumonia. In a minority of patients, extrapulmonary organs (central nervous system, eyes, heart, and gut) are affected, with detection of viral RNA in bodily secretions (stool, tears, and saliva). Infection of such extrapulmonary organs may serve as a reservoir for SARS-CoV-2, representing a potential source of viral shedding after the cessation of respiratory symptoms in recovered patients or in asymptomatic individuals. It is extremely important to understand this phenomenon, as individuals with intermittent virus shedding could be falsely identified as reinfected and may benefit from ongoing antiviral treatment. The potential of SARS-CoV-2 infection to rapidly disseminate and infect extrapulmonary organs is likely mediated through the nonstructural and accessory proteins of SARS-CoV-2, which act as ligands for host cells, and through evasion of host immune responses.

Get statistics on the progression of the pandemic:  http://covidvisualizer.com 

Share this post

Share on facebook
Share on twitter
Share on linkedin